Lipid Transport Disorder Italian Genetic Record (LIPIGEN)

Launched by FONDAZIONE SISA (SOCIETA ITALIANA PER LO STUDIO DELLA ARTERIOSCLEROSI) · Apr 8, 2024

Keywords

ClinConnect Summary

The LIPIGEN study is an important research project happening in Italy that focuses on understanding and improving the diagnosis and treatment of genetic conditions related to cholesterol levels, specifically familial hypercholesterolemia (FH) and other related disorders. This study is observational, meaning that it collects information about patients during their regular doctor visits without requiring any extra tests or procedures. Researchers will gather data on patients' medical history, clinical findings, and genetic information to learn more about these conditions and how effective different treatments are over time.

Anyone of any age who has been diagnosed with familial hypercholesterolemia or another genetic lipid disorder can participate in the study. Participants will continue their routine medical care, and some may undergo additional evaluations like ultrasounds to help understand their condition better. The goal of the LIPIGEN study is not only to enhance our knowledge of high cholesterol-related diseases but also to improve the lives of patients by providing more accurate diagnoses and personalized treatment options.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Molecular or clinical diagnosis of genetic dyslipidemia
• • Informed consent signed
• Exclusion Criteria:
• • None